Cargando…

Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening

BACKGROUND: Infectious disease screening of migrants at increased risk is a feature of national infection prevention and control measures. Asylum seekers in Finland are offered screening of tuberculosis (TB), hepatitis B, human immunodeficiency virus infection (HIV) and syphilis based on individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiittala, Paula, Tuomisto, Karolina, Puumalainen, Taneli, Lyytikäinen, Outi, Ollgren, Jukka, Snellman, Olli, Helve, Otto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154941/
https://www.ncbi.nlm.nih.gov/pubmed/30249224
http://dx.doi.org/10.1186/s12889-018-6038-9
_version_ 1783357792610942976
author Tiittala, Paula
Tuomisto, Karolina
Puumalainen, Taneli
Lyytikäinen, Outi
Ollgren, Jukka
Snellman, Olli
Helve, Otto
author_facet Tiittala, Paula
Tuomisto, Karolina
Puumalainen, Taneli
Lyytikäinen, Outi
Ollgren, Jukka
Snellman, Olli
Helve, Otto
author_sort Tiittala, Paula
collection PubMed
description BACKGROUND: Infectious disease screening of migrants at increased risk is a feature of national infection prevention and control measures. Asylum seekers in Finland are offered screening of tuberculosis (TB), hepatitis B, human immunodeficiency virus infection (HIV) and syphilis based on individual risk assessment. We aimed to evaluate the public health response to a large influx of asylum seekers to Finland in 2015–2016 with respect to national guidelines on initial health services and infectious disease screening. METHODS: We used immigration and healthcare procurement data for all 38,134 asylum seekers to Finland during 2015–2016 to assess the implementation, timing and yields of infectious disease screening. RESULTS: The coverage of pulmonary TB screening was 71.6% [95% CI 71.1–72.0%] and that of hepatitis B, HIV or syphilis 60.6% [60.1–61.1%] among those eligible for screening. The estimated average delay from arrival to pulmonary TB screening was 74 days for adults and 43 days for children. Delay to hepatitis B, HIV and syphilis screening was 91 days for adults and 47 days for children. The seroprevalence of hepatitis B surface antigen positivity was 1.4% [95% CI 1.3–1.6%], HIV 0.3% [95% CI 0.1–0.4%] and Treponema pallidum specific antibodies 1.0% [95% CI 0.8–1.1%]. Data did not allow assessment of yields of pulmonary TB screening. CONCLUSIONS: Up to one third  of asylum seekers were not reached by screening and screenings were delayed from target timeframes. Children, as a vulnerable population, were screened earlier than adults. To ensure higher screening coverage, infectious disease risks should be reassessed and screening completed at contacts to healthcare during the post-asylum phase of integration. The large influx of asylum seekers to Finland in 2015–2016 tested the country’s public health preparedness. After action reviews of the public health response to the large migrant influx such as screening implementation can be used for evidence-based improvement of public health preparedness and guidelines for initial health services and infectious disease screening.
format Online
Article
Text
id pubmed-6154941
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61549412018-09-26 Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening Tiittala, Paula Tuomisto, Karolina Puumalainen, Taneli Lyytikäinen, Outi Ollgren, Jukka Snellman, Olli Helve, Otto BMC Public Health Research Article BACKGROUND: Infectious disease screening of migrants at increased risk is a feature of national infection prevention and control measures. Asylum seekers in Finland are offered screening of tuberculosis (TB), hepatitis B, human immunodeficiency virus infection (HIV) and syphilis based on individual risk assessment. We aimed to evaluate the public health response to a large influx of asylum seekers to Finland in 2015–2016 with respect to national guidelines on initial health services and infectious disease screening. METHODS: We used immigration and healthcare procurement data for all 38,134 asylum seekers to Finland during 2015–2016 to assess the implementation, timing and yields of infectious disease screening. RESULTS: The coverage of pulmonary TB screening was 71.6% [95% CI 71.1–72.0%] and that of hepatitis B, HIV or syphilis 60.6% [60.1–61.1%] among those eligible for screening. The estimated average delay from arrival to pulmonary TB screening was 74 days for adults and 43 days for children. Delay to hepatitis B, HIV and syphilis screening was 91 days for adults and 47 days for children. The seroprevalence of hepatitis B surface antigen positivity was 1.4% [95% CI 1.3–1.6%], HIV 0.3% [95% CI 0.1–0.4%] and Treponema pallidum specific antibodies 1.0% [95% CI 0.8–1.1%]. Data did not allow assessment of yields of pulmonary TB screening. CONCLUSIONS: Up to one third  of asylum seekers were not reached by screening and screenings were delayed from target timeframes. Children, as a vulnerable population, were screened earlier than adults. To ensure higher screening coverage, infectious disease risks should be reassessed and screening completed at contacts to healthcare during the post-asylum phase of integration. The large influx of asylum seekers to Finland in 2015–2016 tested the country’s public health preparedness. After action reviews of the public health response to the large migrant influx such as screening implementation can be used for evidence-based improvement of public health preparedness and guidelines for initial health services and infectious disease screening. BioMed Central 2018-09-24 /pmc/articles/PMC6154941/ /pubmed/30249224 http://dx.doi.org/10.1186/s12889-018-6038-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tiittala, Paula
Tuomisto, Karolina
Puumalainen, Taneli
Lyytikäinen, Outi
Ollgren, Jukka
Snellman, Olli
Helve, Otto
Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening
title Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening
title_full Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening
title_fullStr Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening
title_full_unstemmed Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening
title_short Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening
title_sort public health response to large influx of asylum seekers: implementation and timing of infectious disease screening
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154941/
https://www.ncbi.nlm.nih.gov/pubmed/30249224
http://dx.doi.org/10.1186/s12889-018-6038-9
work_keys_str_mv AT tiittalapaula publichealthresponsetolargeinfluxofasylumseekersimplementationandtimingofinfectiousdiseasescreening
AT tuomistokarolina publichealthresponsetolargeinfluxofasylumseekersimplementationandtimingofinfectiousdiseasescreening
AT puumalainentaneli publichealthresponsetolargeinfluxofasylumseekersimplementationandtimingofinfectiousdiseasescreening
AT lyytikainenouti publichealthresponsetolargeinfluxofasylumseekersimplementationandtimingofinfectiousdiseasescreening
AT ollgrenjukka publichealthresponsetolargeinfluxofasylumseekersimplementationandtimingofinfectiousdiseasescreening
AT snellmanolli publichealthresponsetolargeinfluxofasylumseekersimplementationandtimingofinfectiousdiseasescreening
AT helveotto publichealthresponsetolargeinfluxofasylumseekersimplementationandtimingofinfectiousdiseasescreening